Merck KGaA's Millipore Division Posts $796M in Q3 Revenues | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Merck KGaA reported today that its Merck Millipore division had total revenues of €574 million ($795.9 million) for the third quarter.

Of that total, €314 million ($435.4 million) was attributable to Millipore, which had revenues of $412 million for the third quarter of 2009 as a stand-alone company.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: new chromatin imaging approach, and more.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.